Question 1

Why do nondepolarizing blockers have fewer adverse effects than depolarizing blockers?

Accepted Answer

Nondepolarizing competitive neuromuscular blockers have minimal side effects compared to depolarizing agents like succinylcholine. While nondepolarizing blockers may cause hypotension, depolarizing blockers trigger severe complications including cardiac arrhythmia, postoperative muscle pain, prolonged apnea, and respiratory arrest. The difference stems from their distinct mechanisms of action at the neuromuscular junction.

Question 2

What happens to patients with mutated cholinesterases when given succinylcholine?

Accepted Answer

Patients with mutated cholinesterases cannot metabolize and eliminate succinylcholine properly, leading to delayed muscle recovery. The diaphragm remains paralyzed longer than normal, causing apnea where sedated patients stop breathing. Correct dosing of succinylcholine becomes essential for these at-risk patients to prevent respiratory complications.

Question 3

Why is succinylcholine contraindicated in patients with burns or kidney failure?

Accepted Answer

Succinylcholine facilitates potassium release from intracellular storage, raising serum levels dangerously. Patients with burns, nerve damage, or kidney failure have already suffered rapid potassium loss and cannot tolerate additional increases. Administering succinylcholine to these patients risks hyperkalemia and cardiac arrest, making avoidance critical for patient safety.

Question 4

What adverse effects are associated with directly acting muscle relaxants like dantrolene?

Accepted Answer

Directly acting muscle relaxants including dantrolene and botulinum toxin cause general muscle weakness and hepatotoxicity. Botulinum toxin additionally causes respiratory tract infections and loss of bladder control. These adverse effects require careful patient monitoring and appropriate dose management to minimize complications.

Question 5

How do centrally acting muscle relaxants affect the central nervous system?

Accepted Answer

Centrally acting muscle relaxants induce central nervous system depression with varied symptoms. Tizanidine causes drowsiness, hypotension, dizziness, dry mouth, and hepatotoxicity. Diazepam causes anxiety, tremors, insomnia, and hallucinations. These CNS effects require careful monitoring, especially in vulnerable populations like epileptic or pregnant patients.

Question 6

What complications can occur if baclofen is stopped abruptly?

Accepted Answer

Abrupt discontinuation of baclofen, a nondepolarizing blocker, leads to recurrence of spastic conditions. Patients experience return of muscle spasticity and related symptoms. Gradual tapering rather than sudden cessation is recommended to prevent these rebound adverse effects and maintain therapeutic benefit.

Question 7

How can healthcare providers reduce adverse effects from skeletal muscle relaxants?

Accepted Answer

Administering appropriate drug doses and avoiding high doses in at-risk populations helps minimize adverse effects. Special caution applies to epileptic patients and pregnant women who face increased severity of side effects. Proper patient selection, dose regulation, and monitoring are essential strategies for safe skeletal muscle relaxant use.

骨格筋弛緩剤：副作用